Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2003
10/30/2003US20030202946 Bactericides
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003DE20312772U1 New solid, crystalline forms of ondansetron, useful e.g. for treating emesis, migraine or schizophrenia, having specific endothermal melting peak, base content or water content
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483409A1 (20s)-1.alpha.-hydroxy-2.alpha.-methyl and 2.beta.-methyl-19-nor-vitamin d3 and their uses
10/30/2003CA2483010A1 Placental derived stem cells and uses thereof
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481972A1 Methods of treating ileus
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003CA2481786A1 Methods of treating necrotizing enterocolitis
10/30/2003CA2481753A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003CA2481749A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2478991A1 Compositions and methods for augmenting kidney function
10/29/2003EP1357187A1 Novel physiologically active peptide and use thereof
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357129A2 Novel physiologically active peptide and use thereof
10/29/2003EP1357120A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
10/29/2003EP1356810A1 TNFa PRODUCTION INHIBITORS
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355947A2 Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
10/29/2003EP1355904A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355892A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355881A2 An improved process for preparing pure ondansetron hydrochloride dihydrate
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355870A1 Thiazolamines and their use as tgf-beta inhibitors
10/29/2003EP1355672A2 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
10/29/2003EP1355654A1 Lower alcohol-insoluble extract of hovenia dulcis var. koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1355642A2 INHIBITION OF NF-(k)B BY TRITERPENE COMPOSITIONS
10/29/2003EP1355639A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
10/29/2003EP1355635A1 New film coating
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1355588A2 Delivery of therapeutic capable agents
10/29/2003EP1355541A1 Alpha-lactalbumin as prebiotic agent
10/29/2003EP1257527B1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1169316B9 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/29/2003EP1094834B1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
10/29/2003EP0921787B1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
10/29/2003EP0831822B1 The use of calcium channel antagonists for treating cardiac, renal and gastrointestinal disorders and hypertension
10/29/2003CN1452622A Piperzine devivs.
10/29/2003CN1452498A 药物活性化合物 Pharmaceutically active compounds
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1452488A Treatment of inflammatory disorders
10/29/2003CN1452486A Pharmaceutical composition and use method
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451739A Sedative kidney-reinforcing medicinal liquor
10/29/2003CN1451429A Chinese medicine for treating bacillary dysentery and producing method thereof
10/29/2003CN1451425A Medicine for treating chronic gastritis and preparing process thereof
10/29/2003CN1451417A Process for preparing novel form of ease pill
10/29/2003CN1451413A Flavoured siberian solomonseal rhizome decoction and preparing process thereof
10/29/2003CN1451406A Improved process for preparing Chinese medicine capsule for treating constipation
10/29/2003CN1451399A Superfine gastrodia tuber and American ginseng powder buccal lozenge
10/29/2003CN1451394A Superfine pearl powder and producing process thereof
10/29/2003CN1451390A Medicine use of cyclodextrin derivs. and medicine composition thereof
10/29/2003CN1451389A Agent for promoting cell activation for external use
10/29/2003CN1451388A Medicine for preventing and treating infectious diseases caused by virus, e.g. SARS
10/29/2003CN1451381A Process for preparing medicinal preparation contg. sulfonium methyl methionine chloride
10/29/2003CN1125823C Ganciclovir sodium hydrate and its preparing process and application
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/29/2003CN1125651C Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/29/2003CN1125649C Medicine for treating odontopathy
10/29/2003CN1125642C Pharmaceuticals for treating gastroducdenal ulcer and gastritis and its prepn. process
10/29/2003CN1125640C Prophylactic and therapeutic agent for inflammatory intestinal diseases
10/29/2003CN1125637C Application of 5,3',5'-trihydroxy-7-methoxyl dihydroflavone in preparing medicine
10/28/2003US6639111 Bind on EP4 subtype receptor selectively and binds on the other subtype receptors weakly; side-effect reduction; autoimmune diseases; asthma; bone disorders; degenerative nerve diseases; sleeping disorders; anticoagulants
10/28/2003US6639078 Assays for ligands for nuclear receptors
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638951 Medicament has excellent enhancing action on gastrointestinal tract motility, and is orally available with reduced side effects, the agent for therapeutic treatment of digestive diseases, an agent for improving function of gastrointestinal
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638930 Morpholine and thiomorpholine tachykinin receptor antagonists
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638771 Uses an immune reaction to detect soluble liver antigen ("SLA") auto-antibodies
10/28/2003US6638523 Administering carnosic acid and/or carnosol
1 ... 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 ... 1258